A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...

I’m trying to lose the 18 pounds I have gained since the pandemic. It has been hard enough that I’m wondering about Ozempic.

Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...

Excess weight can trigger chronic low-grade inflammation, which has been linked to increased risk for conditions such as heart disease and dementia. GLP-1s work by suppressing appetite and making ...

Scientists have discovered a naturally-occurring molecule that rivals the weight-loss effects of semaglutide-based GLP-1s like Ozempic in animals.

Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.

Despite the promising results, further research is needed before GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...

GLP-1 agonists can also come with other unpleasant side effects, like nausea and constipation. Meanwhile, a nimal testing of BRP showed no sign of these side-effects, or muscle loss, perhaps because ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

Novo’s share price fell 8 per cent on Monday, having previously dived in December after a late-stage trial of CagriSema in ...